Location of Repository

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects

By G A P Hospers, E A Eisenhauer and E G E de Vries
Topics: Regular Article
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:2362304
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (1996). Amifostine and chemotherapy-related thrombocytopenia.
    2. (1994). Evidence for saturable metabolism. Proc Am Soc Clin Oncol 13: abstract #
    3. (1991). High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest 21: 103–110 Alberts DS and Noel JK
    4. (1996). Neurotoxicity of cisplatin 1/2 reduced glutathione in the first-line treatment of advanced ovarian cancer.
    5. (1976). Prediction of the effective radioprotective dose of WR-2721 in humans through an interspecies tissue distribution study.
    6. (1992). prognosis, and protection by WR-2721.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.